W-JCOIN: Kentucky Women's Justice Community Opioid Innovation Network
Study Details
Study Description
Brief Summary
This trial will test the effectiveness of delivering medication for opioid use disorder (MOUD) pre-treatment via telehealth, alone and with peer navigation, to increase MOUD initiation and maintenance in the community following jail release. This trial will focus on incarcerated women in 6 experimental and 3 control sites in Kentucky. Enrollment is not open to the general public.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
N/A |
Detailed Description
This study will incorporate random assignment for two study conditions: medication for opioid use disorder (MOUD) PreTreatment Telehealth or MOUD PreTreatment Telehealth with Peer Navigation using a rigorous randomized block design. Women in the experimental conditions will be stratified by sites (6 sites; 3 urban and 3 non-urban) and by offender classification level of felony versus misdemeanor (due to potential differences in community supervision). Three comparison sites with existing jail-based MOUD treatment for women will not be randomized but will be included in analyses within planned, non-randomized comparisons.
-
MOUD PreTreatment Telehealth: Participants who screen positive for moderate to high-risk opioid use and complete the baseline interview will be connected via telehealth to the community MOUD provider for a psychosocial assessment. The study data coordinator will assist with linking the participant to the community MOUD provider via telehealth, as well as collecting initial in-person biological specimens for medical evaluation. The psychosocial assessment with the community MOUD provider will involve a more detailed examination of OUD using the Diagnostic and Statistical Manual of Mental Disorders (DSM) 5 criteria. Type of medication (naltrexone, buprenorphine, or methadone) will depend on the psychosocial assessment and medical evaluation. Indications for the most appropriate course of treatment will be determined by the community MOUD provider in conjunction with the study participant. Women in this condition will also receive general education about MOUD options including risks and benefits, and they will be given the opportunity to ask questions about the medication. The community MOUD provider will also use motivational interviewing to assess each woman's readiness to engage in MOUD and to better understand possible barriers to MOUD utilization. At the end of the education session, the study participant and the MOUD community provider will develop a re-entry plan for ongoing care, which will include a plan for insurance coverage of medications in the community.
-
MOUD PreTreatment Telehealth + Peer Navigation: In addition to MOUD PreTreatment Telehealth, women in this arm will be connected with a peer, a woman in recovery who is employed by Voices of Hope (VOH) in Lexington, KY. Peer Navigators will be located in Lexington through a partnership with VOH. VOH is a non-profit recovery support organization which provides peer recovery support services. In conjunction with the study data coordinators, the Peer Navigator will schedule an initial session via telehealth with the participant, assist with scheduling a follow-up appointment with the community MOUD provider, and provide recovery support for community MOUD initiation and maintenance. Peer Navigators will be certified Peer Support Specialists trained and supervised by VOH in accordance with state statutory requirements. When a woman returns to the community, Peer Navigators will engage her in weekly telephone recovery services (TRS) for 12 weeks, which may include identifying personal goals and strength-based, practical strategies for success. In addition to MOUD linkages to care, Peer Navigators will suggest strategies to maintain sobriety and improve recovery capital, including safe housing, transportation, financial counseling, continued education, employment skills, and sober social activities.
-
Services as Usual: Women in this arm will not be randomized, but will receive substance abuse treatment as usual in three comparison jail sites. Each of these jails has a women's substance abuse program (SAP) managed by the Kentucky Department of Corrections (KY-DOC with the option to initiate MOUD prior to jail release. These programs operate as modified therapeutic communities with transitional support following release.
Study Design
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| Active Comparator: Services as Usual (SAU) Substance abuse program (SAP) managed by the Kentucky Department of Corrections, with the option to initiate MOUD prior to jail release. |
Other: Services as Usual
Medications to treat opioid use disorder (MOUD) pre-treatment.
|
| Experimental: MOUD Pre-Treatment Telehealth Telehealth connection to a community MOUD provider. |
Behavioral: MOUD Pre-Treatment Telehealth
Opioid use disorder (OUD) assessment, medical evaluation, and medications to treat opioid use disorder (MOUD) education with a MOUD provider during incarceration via telehealth
|
| Experimental: MOUD Pre-Treatment Telehealth and Peer Navigator Telehealth connection to a community MOUD provider, in addition to a peer navigator |
Behavioral: MOUD Pre-Treatment Telehealth and Peer Navigator
Opioid use disorder (OUD) assessment, medical evaluation, and medications to treat opioid use disorder (MOUD) education with a MOUD provider during incarceration via telehealth. Additionally, participants will be connected with a Peer Navigator who will meet with them via telehealth prior to release and provide ongoing support by telephone post-release.
|
Outcome Measures
Primary Outcome Measures
- The number of participants who initiate MOUD [13 months]
Any initiation of MOUD post-release over the study period
Secondary Outcome Measures
- Medication Type [13 months]
Percentage of participants on naltrexone, buprenorphine or methadone.
- Opioid Relapse [13 months]
Percentage of participants relapsing, measured by self-report or drug screen.
- Treatment Retention [13 months]
Length of time in treatment
- Recidivism [12 months]
Percent of participants returning to custody
- Overdose Rates [13 months]
Percentage of participants who overdose (medical attention needed for revival)
- Criminal Activity [12 months]
Percent of participants engaging in criminal activity (self-report or arrest records)
Other Outcome Measures
- Total Annual Intervention Cost [5 years]
Total annual intervention cost
- Average Participant Cost [13 months]
Average intervention cost per participant
- Incremental Cost-Effectiveness Ratio [5 years]
Cost per unit outcome of interventions versus services as usual
- Public Health Cost of Opioid Relapse [5 years]
Cumulative estimated cost of hospitalizations, treatments, loss of work, child welfare, and other services related to relapse.
- Public Safety Cost of Recidivism and Criminal Activity [5 years]
Cumulative estimated cost of return to custody, arrests, and other social costs of recidivism.
Eligibility Criteria
Criteria
Inclusion Criteria:
-
ASSIST opioid (prescription or street) score of 4+
-
Willingness to participate in MOUD pre-treatment
-
Incarceration period of at least 7 days
Exclusion Criteria
• Cognitive impairment
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Hardin County Detention Center | Elizabethtown | Kentucky | United States | 42701 |
| 2 | Harlan County Detention Center | Harlan | Kentucky | United States | 40828 |
| 3 | Marion County Detention Center | Lebanon | Kentucky | United States | 40033 |
| 4 | Grayson County Detention Center | Leitchfield | Kentucky | United States | 42754 |
| 5 | Laurel County Correctional Center | London | Kentucky | United States | 40741 |
| 6 | Pike County Detention Center | Pikeville | Kentucky | United States | 41501 |
| 7 | Shelby County Detention Center | Shelbyville | Kentucky | United States | 40065 |
| 8 | Grant County Detention Center | Williamstown | Kentucky | United States | 41097 |
Sponsors and Collaborators
- Michele Staton
- National Institute on Drug Abuse (NIDA)
Investigators
- Principal Investigator: Michele Staton, MSW, PhD, University of Kentucky
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- 51656
- 1UG1DA050069-01